Immunic, Inc. Announces First Patient Enrolled in Investigator-Sponsored Proof-of-Concept Clinical Trial
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage...
Read MoreImmunic, Inc. (Nasdaq: IMUX), a clinical-stage...
Read MoreLineage Cell Therapeutics, a clinical-stage...
Read MoreNayati Healthcare has launched the...
Read MoreMycoDART, Inc., developer of proprietary...
Read MoreAskBio, the world's foremost clinical...
Read MoreAn experimental drug is helping...
Read MoreSyngene International a research organisation,...
Read MoreMumbai based Wadia hospital which...
Read MoreWindgap Medical, Inc. announced today...
Read MorePolyPid Ltd., a clinical-stage biopharmaceutical...
Read More